• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Randomized Clinical Trials and COVID-19: Managing Expectations.

作者信息

Bauchner Howard, Fontanarosa Phil B

机构信息

Editor in Chief, , Chicago, Illinois.

Executive Editor, , Chicago, Illinois.

出版信息

JAMA. 2020 Jun 9;323(22):2262-2263. doi: 10.1001/jama.2020.8115.

DOI:10.1001/jama.2020.8115
PMID:32364561
Abstract
摘要

相似文献

1
Randomized Clinical Trials and COVID-19: Managing Expectations.随机临床试验与 COVID-19：合理期待管理
JAMA. 2020 Jun 9;323(22):2262-2263. doi: 10.1001/jama.2020.8115.
2
Rapid Dissemination of Protocols for Managing Neurology Inpatients with COVID-19.新型冠状病毒肺炎（COVID-19）神经科住院患者管理方案的快速传播
Ann Neurol. 2020 Aug;88(2):211-214. doi: 10.1002/ana.25774. Epub 2020 Jun 3.
3
COVID-19 Antibody Trials Have Begun.新冠病毒抗体试验已经开始。
JAMA. 2020 Jul 14;324(2):128. doi: 10.1001/jama.2020.11582.
4
HBO2 for COVID-19: Clinical trials at clinicaltrials.gov.用于治疗新冠肺炎的高压氧疗法：美国国立医学图书馆临床试验数据库中的临床试验
Undersea Hyperb Med. 2020 Second Quarter;47(2):299-307.
5
[Experimental treatment for COVID-19 should be undertaken in randomised studies].针对新冠肺炎的实验性治疗应在随机研究中进行。
Tidsskr Nor Laegeforen. 2020 Apr 1;140(7). doi: 10.4045/tidsskr.20.0282. Print 2020 May 5.
6
Pooling Data From Individual Clinical Trials in the COVID-19 Era.汇总新冠疫情时代个体临床试验的数据。
JAMA. 2020 Aug 11;324(6):543-545. doi: 10.1001/jama.2020.13042.
7
Covid-19: NHS hospitals are urged to recruit more patients to Recovery trial to find what treatments work.新冠疫情：英国国民医疗服务体系（NHS）的医院被敦促招募更多患者参与“康复”试验，以找出有效的治疗方法。
BMJ. 2020 Nov 5;371:m4307. doi: 10.1136/bmj.m4307.
8
Editorial: Clinical trial design in the era of COVID-19.社论：新冠疫情时代的临床试验设计
Clin Trials. 2020 Oct;17(5):465-466. doi: 10.1177/1740774520940230. Epub 2020 Jul 10.
9
Clinical Trial End Points in Severe COVID-19.重症新型冠状病毒肺炎的临床试验终点
Mayo Clin Proc. 2020 Aug;95(8):1578-1580. doi: 10.1016/j.mayocp.2020.05.025. Epub 2020 Jun 6.
10
Balancing the need for rapid and rigorous scientific data during early phase of the COVID-19 pandemic: A further role for the scientific community.在新冠疫情早期平衡快速且严谨的科学数据需求：科学界的进一步作用
Eur J Intern Med. 2020 Jul;77:152. doi: 10.1016/j.ejim.2020.05.037. Epub 2020 May 28.

引用本文的文献

1
Global landscape of COVID-19 research: a visualization analysis of randomized clinical trials.COVID-19 研究的全球格局：随机临床试验的可视化分析。
Clin Exp Med. 2024 Jan 22;24(1):14. doi: 10.1007/s10238-023-01254-3.
2
Clinical Characteristics, Diagnosis, and Therapeutics of COVID-19: A Review.新型冠状病毒肺炎的临床特征、诊断和治疗：综述。
Curr Med Sci. 2023 Dec;43(6):1066-1074. doi: 10.1007/s11596-023-2797-3. Epub 2023 Oct 14.
3
Best Practices from the American Society of Pain and Neuroscience (ASPN) for Clinical Research During a Pandemic or Emergency.
美国疼痛与神经科学学会（ASPN）关于大流行或紧急情况下临床研究的最佳实践。
J Pain Res. 2023 Feb 1;16:327-339. doi: 10.2147/JPR.S393539. eCollection 2023.
4
Developing a Bayesian hierarchical model for a prospective individual patient data meta-analysis with continuous monitoring.开发一个具有连续监测的前瞻性个体患者数据荟萃分析的贝叶斯分层模型。
BMC Med Res Methodol. 2023 Jan 25;23(1):25. doi: 10.1186/s12874-022-01813-4.
5
Impact of dexamethasone and tocilizumab on hematological parameters in COVID-19 patients with chronic disease.地塞米松和托珠单抗对合并慢性病的COVID-19患者血液学参数的影响
Med Clin (Engl Ed). 2022 Dec 23;159(12):569-574. doi: 10.1016/j.medcle.2022.02.029. Epub 2022 Dec 15.
6
Machine learning-based scoring system to predict in-hospital outcomes in patients hospitalized with COVID-19.基于机器学习的评分系统，用于预测因 COVID-19 住院的患者的院内结局。
Arch Cardiovasc Dis. 2022 Dec;115(12):617-626. doi: 10.1016/j.acvd.2022.08.003. Epub 2022 Oct 22.
7
From Cytokine Storm to Cytokine Breeze: Did Lessons Learned from Immunopathogenesis Improve Immunomodulatory Treatment of Moderate-to-Severe COVID-19?从细胞因子风暴到细胞因子微风：免疫发病机制的经验教训是否改善了中重度新冠肺炎的免疫调节治疗？
Biomedicines. 2022 Oct 18;10(10):2620. doi: 10.3390/biomedicines10102620.
8
A review of clinical efficacy data supporting emergency use authorization for COVID-19 therapeutics and lessons for future pandemics.支持 COVID-19 治疗药物紧急使用授权的临床疗效数据综述及对未来大流行的启示。
Clin Transl Sci. 2022 Oct;15(10):2279-2292. doi: 10.1111/cts.13384. Epub 2022 Aug 21.
9
An ordinal severity scale for COVID-19 retrospective studies using Electronic Health Record data.一种用于利用电子健康记录数据进行COVID-19回顾性研究的序贯严重程度量表。
JAMIA Open. 2022 Jul 9;5(3):ooac066. doi: 10.1093/jamiaopen/ooac066. eCollection 2022 Oct.
10
Impact of dexamethasone and tocilizumab on hematological parameters in COVID-19 patients with chronic disease.地塞米松和托珠单抗对合并慢性病的 COVID-19 患者血液学参数的影响。
Med Clin (Barc). 2022 Dec 23;159(12):569-574. doi: 10.1016/j.medcli.2022.02.013. Epub 2022 Apr 25.